Back to top

Image: Bigstock

Is Vanguard LifeStrategy Growth Fund (VASGX) a Strong Mutual Fund Pick Right Now?

Read MoreHide Full Article

If you've been stuck searching for Mutual Fund Equity Report funds, consider Vanguard LifeStrategy Growth Fund (VASGX - Free Report) as a possibility. VASGX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance.

History of Fund/Manager

VASGX finds itself in the Vanguard Group family, based out of Malvern, PA. The Vanguard LifeStrategy Growth Fund made its debut in September of 1994 and VASGX has managed to accumulate roughly $19.89 billion in assets, as of the most recently available information. The fund's current manager, William Coleman, has been in charge of the fund since February of 2022.

Performance

Of course, investors look for strong performance in funds. This fund carries a 5-year annualized total return of 6.95%, and it sits in the top third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 7.69%, which places it in the middle third during this time-frame.

It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.

When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. Compared to the category average of 14.64%, the standard deviation of VASGX over the past three years is 14.61%. Over the past 5 years, the standard deviation of the fund is 15.14% compared to the category average of 15.41%. This makes the fund less volatile than its peers over the past half-decade.

Risk Factors

With a 5-year beta of 0.79, the fund is likely to be less volatile than the market average. Another factor to consider is alpha, as it reflects a portfolio's performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. VASGX has generated a negative alpha over the past five years of -2.88, demonstrating that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.

Expenses

Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, VASGX is a no load fund. It has an expense ratio of 0.14% compared to the category average of 0.85%. VASGX is actually cheaper than its peers when you consider factors like cost.

This fund requires a minimum initial investment of $3,000, and each subsequent investment should be at least $1.

Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included.

Bottom Line

Overall, Vanguard LifeStrategy Growth Fund ( VASGX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively strong performance, average downside risk, and lower fees, Vanguard LifeStrategy Growth Fund ( VASGX ) looks like a good potential choice for investors right now.

Don't stop here for your research on Mutual Fund Equity Report funds. We also have plenty more on our site in order to help you find the best possible fund for your portfolio. Make sure to check out www.zacks.com/funds/mutual-funds for more information about the world of funds, and feel free to compare VASGX to its peers as well for additional information. If you are more of a stock investor, make sure to also check out our Zacks Rank, and our full suite of tools we have available for novice and professional investors alike.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Vanguard LifeStrategy Growth Inv (VASGX) - free report >>

Published in